CATH Superfamily 2.60.120.200
The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 23: Galectin
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 30 GO terms relating to "molecular function"
			The search results have been sorted with the annotations that are found most frequently at the top of the
			list. The results can be filtered by typing text into the search box at the top of the table.
			
			
	| GO Term | Annotations | Evidence | 
|---|---|---|
| Protein binding GO:0005515 Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). | 7 | O08573 (/IPI) P16110 (/IPI) P17931 (/IPI) P17931 (/IPI) Q3B8N2 (/IPI) Q6DKI2 (/IPI) Q6NVH9 (/IPI) | 
| IgE binding GO:0019863 Interacting selectively and non-covalently with an immunoglobulin of the IgE isotype. | 4 | P08699 (/IDA) P08699 (/IDA) P17931 (/IDA) P17931 (/IDA) | 
| Enzyme binding GO:0019899 Interacting selectively and non-covalently with any enzyme. | 3 | O00182 (/IPI) O00182 (/IPI) O08573 (/IPI) | 
| Carbohydrate binding GO:0030246 Interacting selectively and non-covalently with any carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates. | 3 | O00182 (/IDA) O00182 (/IDA) O08573 (/IDA) | 
| Carbohydrate binding GO:0030246 Interacting selectively and non-covalently with any carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates. | 3 | O08573 (/ISS) P97840 (/ISS) Q3MHZ8 (/ISS) | 
| RNA binding GO:0003723 Interacting selectively and non-covalently with an RNA molecule or a portion thereof. | 2 | P17931 (/HDA) P17931 (/HDA) | 
| Protein phosphatase inhibitor activity GO:0004864 Stops, prevents or reduces the activity of a protein phosphatase, an enzyme that hydrolyzes phosphate groups from phosphorylated proteins. | 2 | P17931 (/IC) P17931 (/IC) | 
| Galactose binding GO:0005534 Interacting selectively and non-covalently with the aldohexose galactose (galacto-hexose), a common constituent of many oligo- and polysaccharides. | 2 | O00182 (/TAS) O00182 (/TAS) | 
| Protein phosphatase binding GO:0019903 Interacting selectively and non-covalently with any protein phosphatase. | 2 | P17931 (/IPI) P17931 (/IPI) | 
| Carbohydrate binding GO:0030246 Interacting selectively and non-covalently with any carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates. | 2 | P17931 (/TAS) P17931 (/TAS) | 
| Fc-gamma receptor I complex binding GO:0034988 Interacting selectively and non-covalently with one or more specific sites on the Fc-gamma receptor I complex. The complex functions primarily as an activating receptor for IgG. | 2 | P08699 (/IDA) P08699 (/IDA) | 
| Chemoattractant activity GO:0042056 Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Laminin binding GO:0043236 Interacting selectively and non-covalently with laminins, glycoproteins that are major constituents of the basement membrane of cells. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Monosaccharide binding GO:0048029 Interacting selectively and non-covalently with any monosaccharide. Monosaccharides are the simplest carbohydrates; they are polyhydroxy aldehydes H | 2 | P08699 (/IDA) P08699 (/IDA) | 
| Disaccharide binding GO:0048030 Interacting selectively and non-covalently with any disaccharide. Disaccharides are sugars composed of two monosaccharide units. | 2 | P08699 (/IDA) P08699 (/IDA) | 
| Disaccharide binding GO:0048030 Interacting selectively and non-covalently with any disaccharide. Disaccharides are sugars composed of two monosaccharide units. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Advanced glycation end-product receptor activity GO:0050785 Combining with advanced glycation end-products and transmitting the signal to initiate a change in cell activity. Advanced glycation end-products (AGEs) form from a series of chemical reactions after an initial glycation event (a non-enzymatic reaction between reducing sugars and free amino groups of proteins). | 2 | P08699 (/IDA) P08699 (/IDA) | 
| Signaling receptor binding GO:0005102 Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. | 1 | O08573 (/IPI) | 
| Galactoside binding GO:0016936 Interacting selectively and non-covalently with any glycoside in which the sugar group is galactose. | 1 | O08573 (/IMP) | 
| Galactoside binding GO:0016936 Interacting selectively and non-covalently with any glycoside in which the sugar group is galactose. | 1 | O08573 (/ISA) | 
| IgE binding GO:0019863 Interacting selectively and non-covalently with an immunoglobulin of the IgE isotype. | 1 | P16110 (/ISO) | 
| Protein phosphatase binding GO:0019903 Interacting selectively and non-covalently with any protein phosphatase. | 1 | P16110 (/ISO) | 
| Carbohydrate binding GO:0030246 Interacting selectively and non-covalently with any carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates. | 1 | O08573 (/IMP) | 
| Fc-gamma receptor I complex binding GO:0034988 Interacting selectively and non-covalently with one or more specific sites on the Fc-gamma receptor I complex. The complex functions primarily as an activating receptor for IgG. | 1 | P16110 (/ISO) | 
| Chemoattractant activity GO:0042056 Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal. | 1 | P16110 (/ISO) | 
| Laminin binding GO:0043236 Interacting selectively and non-covalently with laminins, glycoproteins that are major constituents of the basement membrane of cells. | 1 | P16110 (/ISO) | 
| Protein serine/threonine kinase activator activity GO:0043539 Binds to and increases the activity of a protein serine/threonine kinase. | 1 | O08573 (/IDA) | 
| Monosaccharide binding GO:0048029 Interacting selectively and non-covalently with any monosaccharide. Monosaccharides are the simplest carbohydrates; they are polyhydroxy aldehydes H | 1 | P16110 (/ISO) | 
| Disaccharide binding GO:0048030 Interacting selectively and non-covalently with any disaccharide. Disaccharides are sugars composed of two monosaccharide units. | 1 | P16110 (/ISO) | 
| Advanced glycation end-product receptor activity GO:0050785 Combining with advanced glycation end-products and transmitting the signal to initiate a change in cell activity. Advanced glycation end-products (AGEs) form from a series of chemical reactions after an initial glycation event (a non-enzymatic reaction between reducing sugars and free amino groups of proteins). | 1 | P16110 (/ISO) | 
There are 123 GO terms relating to "biological process"
			The search results have been sorted with the annotations that are found most frequently at the top of the
			list. The results can be filtered by typing text into the search box at the top of the table.
			
			
	| GO Term | Annotations | Evidence | 
|---|---|---|
| Female pregnancy GO:0007565 The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. | 3 | O00182 (/IDA) O00182 (/IDA) O08573 (/IDA) | 
| Negative regulation of gene expression GO:0010629 Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. | 3 | O00182 (/IMP) O00182 (/IMP) O08573 (/IMP) | 
| Response to lipopolysaccharide GO:0032496 Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. | 3 | O00182 (/IMP) O00182 (/IMP) O08573 (/IMP) | 
| Cellular response to virus GO:0098586 Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus. | 3 | O00182 (/IMP) O00182 (/IMP) O08573 (/IMP) | 
| Positive regulation of interleukin-6 secretion GO:2000778 Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion. | 3 | O00182 (/IMP) O00182 (/IMP) O08573 (/IMP) | 
| Natural killer cell tolerance induction GO:0002519 Tolerance induction of natural killer cells. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Monocyte chemotaxis GO:0002548 The movement of a monocyte in response to an external stimulus. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Inflammatory response GO:0006954 The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of cell population proliferation GO:0008284 Any process that activates or increases the rate or extent of cell proliferation. | 2 | P08699 (/IMP) P08699 (/IMP) | 
| Positive regulation of gene expression GO:0010628 Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Negative regulation of gene expression GO:0010629 Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of serotonin secretion GO:0014064 Any process that activates or increases the frequency, rate or extent of the regulated release of serotonin. | 2 | P08699 (/IDA) P08699 (/IDA) | 
| Neutrophil chemotaxis GO:0030593 The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Epithelial cell differentiation GO:0030855 The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium. | 2 | P17931 (/IEP) P17931 (/IEP) | 
| Negative regulation of chemokine production GO:0032682 Any process that stops, prevents, or reduces the frequency, rate, or extent of chemokine production. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Negative regulation of interferon-gamma production GO:0032689 Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Negative regulation of tumor necrosis factor production GO:0032720 Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Positive regulation of interleukin-4 production GO:0032753 Any process that activates or increases the frequency, rate, or extent of interleukin-4 production. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of interleukin-4 production GO:0032753 Any process that activates or increases the frequency, rate, or extent of interleukin-4 production. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response GO:0032834 Any process that activates or increases the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells as part of an immune response. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| P38MAPK cascade GO:0038066 An intracellular protein kinase cascade containing at least a p38 MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Regulation of T cell proliferation GO:0042129 Any process that modulates the frequency, rate or extent of T cell proliferation. | 2 | P17931 (/IMP) P17931 (/IMP) | 
| Negative regulation of apoptotic process GO:0043066 Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. | 2 | P08699 (/IDA) P08699 (/IDA) | 
| Positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123 Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling. | 2 | O00182 (/HMP) O00182 (/HMP) | 
| Negative regulation of mast cell degranulation GO:0043305 Any process that stops, prevents, or reduces the rate of mast cell degranulation. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Neutrophil degranulation GO:0043312 The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil. | 2 | P17931 (/TAS) P17931 (/TAS) | 
| Regulation of myeloid cell differentiation GO:0045637 Any process that modulates the frequency, rate or extent of myeloid cell differentiation. | 2 | P17931 (/TAS) P17931 (/TAS) | 
| Positive regulation of angiogenesis GO:0045766 Any process that activates or increases angiogenesis. | 2 | P08699 (/IMP) P08699 (/IMP) | 
| Negative regulation of endocytosis GO:0045806 Any process that stops, prevents, or reduces the frequency, rate or extent of endocytosis. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Negative regulation of natural killer cell mediated cytotoxicity GO:0045953 Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Negative regulation of activated T cell proliferation GO:0046007 Any process that stops, prevents or reduces the rate or extent of activated T cell proliferation. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Positive regulation of viral entry into host cell GO:0046598 Any process that activates or increases the frequency, rate or extent of the introduction of viral entry into the host cell. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Eosinophil chemotaxis GO:0048245 The movement of an eosinophil in response to an external stimulus. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Macrophage chemotaxis GO:0048246 The movement of a macrophage in response to an external stimulus. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Positive regulation of interleukin-1 beta secretion GO:0050718 Any process that activates or increases the frequency, rate or extent of the regulated release of interleukin-1 beta from a cell. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Negative regulation of T cell receptor signaling pathway GO:0050860 Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell. | 2 | P17931 (/ISS) P17931 (/ISS) | 
| Positive chemotaxis GO:0050918 The directed movement of a motile cell or organism towards a higher concentration of a chemical. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Positive regulation of NF-kappaB transcription factor activity GO:0051092 Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Maternal process involved in female pregnancy GO:0060135 A reproductive process occurring in the mother that allows an embryo or fetus to develop within it. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Regulation of T cell apoptotic process GO:0070232 Any process that modulates the occurrence or rate of T cell death by apoptotic process. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Positive regulation of activated T cell autonomous cell death GO:0070241 Any process that activates or increases the frequency, rate or extent of activated T cell autonomous cell death. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| ERK1 and ERK2 cascade GO:0070371 An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade may involve 4 different kinases, as it can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of ERK1 and ERK2 cascade GO:0070374 Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Response to interleukin-1 GO:0070555 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Cellular response to interferon-gamma GO:0071346 Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of transforming growth factor beta production GO:0071636 Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of monocyte chemotactic protein-1 production GO:0071639 Any process that activates or increases the frequency, rate, or extent of production of monocyte chemotactic protein-1. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Mononuclear cell migration GO:0071674 The movement of a mononuclear cell within or between different tissues and organs of the body. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Positive regulation of mononuclear cell migration GO:0071677 Any process that increases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Positive regulation of protein homodimerization activity GO:0090073 Any process that increases the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Positive regulation of calcium ion import GO:0090280 Any process that increases the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Positive regulation of NIK/NF-kappaB signaling GO:1901224 Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902041 Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. | 2 | P17931 (/IMP) P17931 (/IMP) | 
| Positive regulation of interferon-gamma secretion GO:1902715 Any process that activates or increases the frequency, rate or extent of interferon-gamma secretion. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of protein localization to plasma membrane GO:1903078 Any process that activates or increases the frequency, rate or extent of protein localization to plasma membrane. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Negative regulation of protein tyrosine phosphatase activity GO:1903614 Any process that stops, prevents or reduces the frequency, rate or extent of protein tyrosine phosphatase activity. | 2 | P17931 (/IC) P17931 (/IC) | 
| Negative regulation of cell proliferation in bone marrow GO:1903769 Any process that stops, prevents or reduces the frequency, rate or extent of cell proliferation in bone marrow. | 2 | P08699 (/IDA) P08699 (/IDA) | 
| Positive regulation of tumor necrosis factor secretion GO:1904469 Any process that activates or increases the frequency, rate or extent of tumor necrosis factor secretion. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of interleukin-8 secretion GO:2000484 Any process that activates or increases the frequency, rate or extent of interleukin-8 secretion. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Positive regulation of dendritic cell chemotaxis GO:2000510 Any process that activates or increases the frequency, rate or extent of dendritic cell chemotaxis. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Negative regulation of immunological synapse formation GO:2000521 Any process that stops, prevents or reduces the frequency, rate or extent of immunological synapse formation. | 2 | P17931 (/ISS) P17931 (/ISS) | 
| Negative regulation of CD4-positive, alpha-beta T cell proliferation GO:2000562 Any process that stops, prevents or reduces the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of CD4-positive, alpha-beta T cell proliferation GO:2000563 Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of interleukin-13 secretion GO:2000667 Any process that activates or increases the frequency, rate or extent of interleukin-13 secretion. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of dendritic cell apoptotic process GO:2000670 Any process that activates or increases the frequency, rate or extent of dendritic cell apoptotic process. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of interleukin-10 secretion GO:2001181 Any process that activates or increases the frequency, rate or extent of interleukin-10 secretion. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of interleukin-12 secretion GO:2001184 Any process that activates or increases the frequency, rate or extent of interleukin-12 secretion. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell GO:2001189 Any process that stops, prevents or reduces the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell. | 2 | P17931 (/ISS) P17931 (/ISS) | 
| Positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell GO:2001190 Any process that activates or increases the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell. | 2 | O00182 (/IDA) O00182 (/IDA) | 
| Positive regulation of dendritic cell differentiation GO:2001200 Any process that activates or increases the frequency, rate or extent of dendritic cell differentiation. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Negative regulation of extrinsic apoptotic signaling pathway GO:2001237 Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway GO:2001269 Any process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway. | 2 | O00182 (/IMP) O00182 (/IMP) | 
| Skeletal system development GO:0001501 The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton). | 1 | P16110 (/IGI) | 
| Positive regulation of cytokine production GO:0001819 Any process that activates or increases the frequency, rate or extent of production of a cytokine. | 1 | O08573 (/IMP) | 
| Monocyte chemotaxis GO:0002548 The movement of a monocyte in response to an external stimulus. | 1 | P16110 (/ISO) | 
| Heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules GO:0007157 The attachment of an adhesion molecule in one cell to a nonidentical adhesion molecule in an adjacent cell. | 1 | O08573 (/ISA) | 
| Positive regulation of cell population proliferation GO:0008284 Any process that activates or increases the rate or extent of cell proliferation. | 1 | P16110 (/ISO) | 
| Positive regulation of gene expression GO:0010628 Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. | 1 | O08573 (/IMP) | 
| Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862 Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. | 1 | O08573 (/IMP) | 
| Positive regulation of serotonin secretion GO:0014064 Any process that activates or increases the frequency, rate or extent of the regulated release of serotonin. | 1 | P16110 (/ISO) | 
| Extracellular matrix organization GO:0030198 A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix. | 1 | P16110 (/IGI) | 
| Neutrophil chemotaxis GO:0030593 The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding. | 1 | P16110 (/ISO) | 
| Negative regulation of interferon-gamma production GO:0032689 Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. | 1 | O08573 (/IMP) | 
| Positive regulation of chemokine production GO:0032722 Any process that activates or increases the frequency, rate, or extent of chemokine production. | 1 | O08573 (/IMP) | 
| Positive regulation of interleukin-1 production GO:0032732 Any process that activates or increases the frequency, rate, or extent of interleukin-1 production. | 1 | O08573 (/IMP) | 
| Positive regulation of tumor necrosis factor production GO:0032760 Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production. | 1 | O08573 (/IMP) | 
| Negative regulation of natural killer cell activation GO:0032815 Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer cell activation. | 1 | O08573 (/IMP) | 
| Regulation of natural killer cell differentiation GO:0032823 Any process that modulates the frequency, rate or extent of natural killer cell differentiation. | 1 | O08573 (/IMP) | 
| Toll-like receptor 3 signaling pathway GO:0034138 Any series of molecular signals generated as a consequence of binding to toll-like receptor 3. | 1 | P97840 (/IMP) | 
| Toll-like receptor 3 signaling pathway GO:0034138 Any series of molecular signals generated as a consequence of binding to toll-like receptor 3. | 1 | O08573 (/ISO) | 
| Regulation of T cell proliferation GO:0042129 Any process that modulates the frequency, rate or extent of T cell proliferation. | 1 | P16110 (/ISO) | 
| Positive regulation of macrophage activation GO:0043032 Any process that stimulates, induces or increases the rate of macrophage activation. | 1 | O08573 (/IMP) | 
| Negative regulation of apoptotic process GO:0043066 Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. | 1 | P16110 (/ISO) | 
| Negative regulation of natural killer cell degranulation GO:0043322 Any process that stops, prevents, or reduces the rate of natural killer cell degranulation. | 1 | O08573 (/IMP) | 
| Positive regulation of innate immune response GO:0045089 Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection. | 1 | O08573 (/IMP) | 
| Maintenance of protein location GO:0045185 Any process in which a protein is maintained in a location and prevented from moving elsewhere. These include sequestration, stabilization to prevent transport elsewhere and the active retrieval of proteins that do move away. | 1 | O08573 (/IDA) | 
| Positive regulation of regulatory T cell differentiation GO:0045591 Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells. | 1 | O08573 (/IMP) | 
| Positive regulation of angiogenesis GO:0045766 Any process that activates or increases angiogenesis. | 1 | P16110 (/ISO) | 
| Negative regulation of endocytosis GO:0045806 Any process that stops, prevents, or reduces the frequency, rate or extent of endocytosis. | 1 | P16110 (/IMP) | 
| Negative regulation of endocytosis GO:0045806 Any process that stops, prevents, or reduces the frequency, rate or extent of endocytosis. | 1 | P16110 (/ISO) | 
| Eosinophil chemotaxis GO:0048245 The movement of an eosinophil in response to an external stimulus. | 1 | P16110 (/ISO) | 
| Macrophage chemotaxis GO:0048246 The movement of a macrophage in response to an external stimulus. | 1 | P16110 (/ISO) | 
| Negative regulation of inflammatory response GO:0050728 Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. | 1 | O08573 (/IMP) | 
| Negative regulation of T cell receptor signaling pathway GO:0050860 Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell. | 1 | P16110 (/IMP) | 
| Positive chemotaxis GO:0050918 The directed movement of a motile cell or organism towards a higher concentration of a chemical. | 1 | P16110 (/ISO) | 
| Positive regulation of oxidoreductase activity GO:0051353 Any process that activates or increases the frequency, rate or extent of oxidoreductase activity, the catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. | 1 | O08573 (/IDA) | 
| Regulation of T cell apoptotic process GO:0070232 Any process that modulates the occurrence or rate of T cell death by apoptotic process. | 1 | P16110 (/ISO) | 
| Mononuclear cell migration GO:0071674 The movement of a mononuclear cell within or between different tissues and organs of the body. | 1 | P16110 (/ISO) | 
| Positive regulation of mononuclear cell migration GO:0071677 Any process that increases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body. | 1 | P16110 (/ISO) | 
| Positive regulation of protein homodimerization activity GO:0090073 Any process that increases the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer. | 1 | P16110 (/ISO) | 
| Positive regulation of calcium ion import GO:0090280 Any process that increases the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle. | 1 | P16110 (/ISO) | 
| Positive regulation of defense response to bacterium GO:1900426 Any process that activates or increases the frequency, rate or extent of defense response to bacterium. | 1 | O08573 (/IMP) | 
| Regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902041 Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. | 1 | P16110 (/ISO) | 
| Negative regulation of interferon-gamma secretion GO:1902714 Any process that stops, prevents or reduces the frequency, rate or extent of interferon-gamma secretion. | 1 | O08573 (/IDA) | 
| Positive regulation of protein localization to plasma membrane GO:1903078 Any process that activates or increases the frequency, rate or extent of protein localization to plasma membrane. | 1 | P16110 (/ISO) | 
| Negative regulation of cell proliferation in bone marrow GO:1903769 Any process that stops, prevents or reduces the frequency, rate or extent of cell proliferation in bone marrow. | 1 | P16110 (/ISO) | 
| Positive regulation of T cell migration GO:2000406 Any process that activates or increases the frequency, rate or extent of T cell migration. | 1 | O08573 (/IDA) | 
| Negative regulation of immunological synapse formation GO:2000521 Any process that stops, prevents or reduces the frequency, rate or extent of immunological synapse formation. | 1 | P16110 (/IMP) | 
| Negative regulation of CD4-positive, alpha-beta T cell proliferation GO:2000562 Any process that stops, prevents or reduces the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation. | 1 | O08573 (/IMP) | 
| Positive regulation of transcription regulatory region DNA binding GO:2000679 Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding. | 1 | O08573 (/IMP) | 
| Positive regulation of interleukin-10 secretion GO:2001181 Any process that activates or increases the frequency, rate or extent of interleukin-10 secretion. | 1 | O08573 (/IMP) | 
| Negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell GO:2001189 Any process that stops, prevents or reduces the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell. | 1 | P16110 (/IMP) | 
| Negative regulation of extrinsic apoptotic signaling pathway GO:2001237 Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway. | 1 | P16110 (/ISO) | 
There are 27 GO terms relating to "cellular component"
			The search results have been sorted with the annotations that are found most frequently at the top of the
			list. The results can be filtered by typing text into the search box at the top of the table.
			
			
	| GO Term | Annotations | Evidence | 
|---|---|---|
| Nucleus GO:0005634 A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. | 8 | O00182 (/IDA) O00182 (/IDA) O08573 (/IDA) P08699 (/IDA) P08699 (/IDA) P16110 (/IDA) P17931 (/IDA) P17931 (/IDA) | 
| Cytoplasm GO:0005737 All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. | 8 | O00182 (/IDA) O00182 (/IDA) O08573 (/IDA) P08699 (/IDA) P08699 (/IDA) P16110 (/IDA) P17931 (/IDA) P17931 (/IDA) | 
| Cytosol GO:0005829 The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. | 8 | A0A024QZ02 (/IDA) A0A024QZ55 (/IDA) A0A024QZ55 (/IDA) J3KSY2 (/IDA) O00182 (/IDA) O00182 (/IDA) Q3B8N2 (/IDA) Q6DKI2 (/IDA) | 
| Collagen-containing extracellular matrix GO:0062023 An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells. | 6 | O00182 (/HDA) O00182 (/HDA) O08573 (/HDA) P16110 (/HDA) P17931 (/HDA) P17931 (/HDA) | 
| Extracellular space GO:0005615 That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. | 4 | O00182 (/IDA) O00182 (/IDA) P08699 (/IDA) P08699 (/IDA) | 
| Plasma membrane GO:0005886 The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. | 4 | P08699 (/TAS) P08699 (/TAS) P17931 (/TAS) P17931 (/TAS) | 
| Immunological synapse GO:0001772 An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction. | 3 | P16110 (/IDA) P17931 (/IDA) P17931 (/IDA) | 
| Extracellular space GO:0005615 That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. | 3 | P16110 (/HDA) P17931 (/HDA) P17931 (/HDA) | 
| Cell surface GO:0009986 The external part of the cell wall and/or plasma membrane. | 3 | P08699 (/IDA) P08699 (/IDA) P16110 (/IDA) | 
| Extracellular region GO:0005576 The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. | 2 | P17931 (/HDA) P17931 (/HDA) | 
| Extracellular region GO:0005576 The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. | 2 | O08573 (/TAS) P16110 (/TAS) | 
| Mitochondrial inner membrane GO:0005743 The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae. | 2 | P17931 (/IDA) P17931 (/IDA) | 
| Cell surface GO:0009986 The external part of the cell wall and/or plasma membrane. | 2 | P17931 (/ISS) P17931 (/ISS) | 
| Membrane GO:0016020 A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. | 2 | P17931 (/HDA) P17931 (/HDA) | 
| Secretory granule membrane GO:0030667 The lipid bilayer surrounding a secretory granule. | 2 | P17931 (/TAS) P17931 (/TAS) | 
| Extracellular exosome GO:0070062 A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. | 2 | P17931 (/HDA) P17931 (/HDA) | 
| Ficolin-1-rich granule membrane GO:0101003 The lipid bilayer surrounding a ficolin-1-rich granule. | 2 | P17931 (/TAS) P17931 (/TAS) | 
| Immunological synapse GO:0001772 An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction. | 1 | P16110 (/ISO) | 
| Extracellular space GO:0005615 That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. | 1 | P16110 (/ISO) | 
| Nucleus GO:0005634 A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. | 1 | P16110 (/ISO) | 
| Cytoplasm GO:0005737 All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. | 1 | P16110 (/ISO) | 
| Mitochondrial inner membrane GO:0005743 The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae. | 1 | P16110 (/ISO) | 
| Cytosol GO:0005829 The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. | 1 | O08573 (/ISO) | 
| External side of plasma membrane GO:0009897 The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. | 1 | P16110 (/IDA) | 
| Cell surface GO:0009986 The external part of the cell wall and/or plasma membrane. | 1 | P16110 (/ISO) | 
| Extracellular matrix GO:0031012 A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues. | 1 | P16110 (/IDA) | 
| Glial cell projection GO:0097386 A prolongation or process extending from a glial cell. | 1 | P16110 (/IDA) | 
